Private Equity

Updated:

Beecken Petty O'Keefe & Company

The capital partner of choice to healthcare leaders. we align with Founders and Operators in pursuit of growth and value creation.

Beecken Petty O'Keefe & Company

The capital partner of choice to healthcare leaders. we align with Founders and Operators in pursuit of growth and value creation.

General information

Firm type

Private Equity

Year founded

1996

AUM

$1B - $5B (Altss estimate)

Location

Region

North America

Country

United States

City

Chicago

Corporate office

Chicago, IL, United States

Principals

David Beecken

Co-Founder & Managing Partner

William Petty

Co-Founder & Managing Partner

Dave O'Keefe

Co-Founder & Managing Partner

Sector focus

Healthcare Services

Frequently asked questions

Who runs investment decisions at Beecken Petty O'Keefe & Company?

The three co-founders — David Beecken, William Petty, and Dave O'Keefe — serve as Managing Partners and sit on the investment committee. The firm has maintained the same partnership leadership since its 1996 founding, with no publicly announced managing-partner departures or succession transitions (per the firm's official communications). Day-to-day deal execution is led by the partner group, supported by a team of investment professionals.

Does BPOC invest exclusively in healthcare, or does it consider other sectors?

BPOC has invested exclusively in healthcare services since inception. The firm's 1996 founding thesis targeted fragmented healthcare services markets, and it has not diversified into other healthcare verticals such as biopharmaceuticals or medical devices. This single-sector constraint applies across all four institutional funds and distinguishes the firm from generalist middle-market private equity managers.

What size companies does BPOC typically acquire?

The firm targets healthcare services platforms with EBITDA between $5 million and $30 million. BPOC writes equity checks typically ranging from $20 million to $100 million per transaction, positioning the firm in the middle-market buyout space. It pursues both platform acquisitions and add-on consolidation strategies within its existing portfolio companies (per the firm's stated investment criteria).

Is BPOC currently investing out of an active fund?

BPOC closed its fourth institutional fund, BPOC Fund IV, in 2017. The firm has not publicly disclosed a specific fund size for Fund IV, nor has it announced a subsequent fundraise as of early 2026. BPOC operates as a traditional closed-end fund manager, deploying committed capital from institutional limited partners rather than raising capital on a deal-by-deal basis.

Where does BPOC source its deal flow?

The firm's two-decade concentration in healthcare services creates a targeted origination network of industry executives, specialty investment banks, and founder referrals. BPOC's stated strategy relies on proprietary sourcing within sub-sectors it knows deeply — physician practice management, behavioral health, and outsourced healthcare services — rather than competitive auction processes where generalist bidders dominate.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Chicago Private Equity profiles